Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS encouraging Part D sponsors to help with pharmacy eRx costs

Executive Summary

CMS is asking Medicare Part D prescription drug plan sponsors to review agreements they have with pharmacy networks to ensure that dispensing fees help address electronic prescription costs. "We believe that it is unlikely that dispensing fees that were negotiated prior to a pharmacy's implementation of e-prescribing factored into these costs," the agency said in a Sept. 19 memo to sponsors. "Therefore, we would expect Part D sponsors to review network dispensing fees to ensure they appropriately reimburse pharmacies for these new costs." The agency also suggested that Part D sponsors could help to spur e-prescribing at the pharmacy level by making an incentive payment to pharmacies that process e-prescriptions and report those amounts as additional dispensing fees



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts